At a Glance
Dosage
oral
| Level | 1cP-MiPLA | AL-LAD |
|---|---|---|
| Threshold | 50 µg | 20 µg |
| Light | 100–150 µg | 50–100 µg |
| Common | 150–200 µg | 100–225 µg |
| Strong | 200–250 µg | 225–350 µg |
| Heavy | 300 µg | 350 µg |
Duration
oral
1cP-MiPLA
oral
Total: 4 hrs – 6 hrsCome Up
Peak
Offset
Afterglow
Onset20 min – 40 min
Come Up45 min – 1.5 hrs
Peak1 hrs – 2 hrs
Effects
Safety
Interaction: 1cP-MiPLA + AL-LAD
No direct interaction data available between these substances. This does not mean the combination is safe.
1cP-MiPLA — Dangerous Interactions
No dangerous interactions recorded.
AL-LAD — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between 1cP-MiPLA and AL-LAD?
1cP-MiPLA is classified as a Psychedelic (Lysergamides) while AL-LAD is classified as a Psychedelic (Lysergamides). They share 67 effects in common, with 3 effects unique to 1cP-MiPLA and 9 unique to AL-LAD.
Is it safe to combine 1cP-MiPLA and AL-LAD?
There is no direct interaction data available for combining 1cP-MiPLA and AL-LAD. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, 1cP-MiPLA or AL-LAD?
At common doses via oral, 1cP-MiPLA is typically dosed at 150–200 µg while AL-LAD is dosed at 100–225 µg. However, "stronger" depends on context — potency, subjective intensity, and duration all factor in. These substances have different pharmacological profiles and comparing raw potency is not straightforward.